NLRP3 inflammasome contributes to endotoxin-induced coagulation

Area of Science:

• Immunology
• Hematology
• Pathophysiology

Background:

• Sepsis can cause life-threatening disseminated intravascular coagulation (DIC) due to overactive coagulation.
• The noncanonical inflammasome plays a role in endotoxin-induced coagulation.
• The NLRP3 inflammasome, a key inflammatory pathway, was investigated for its role in sepsis-induced coagulation.

Purpose of the Study:

• To evaluate the function of the NLRP3 inflammasome in endotoxin-induced coagulation.
• To determine if NLRP3 activation contributes to the development of DIC during sepsis.
• To explore the therapeutic potential of targeting NLRP3 for sepsis-related coagulation.

Main Methods:

• An endotoxin-induced coagulation mouse model using lipopolysaccharide (LPS) was established.
• Coagulation markers (TAT, PAI-1, PT, D-dimer) and IL-1β levels were measured.
• Tissue factor (TF) expression, fibrin deposition, and inflammasome components (NLRP3, ASC, Caspase-11) were analyzed in wild-type and knockout mice, and with NLRP3 inhibition (MCC950).

Main Results:

• NLRP3 or ASC deficiency, and MCC950 treatment, reduced coagulation markers and TF expression.
• Caspase-11 deficiency did not prevent endotoxin-induced coagulation.
• IL-1β release was elevated in Caspase-11 deficient mice but not in NLRP3 deficient mice, and IL-1β correlated positively with coagulation markers and TF.

Conclusions:

• The NLRP3 inflammasome promotes endotoxin-induced coagulation, partly by inducing IL-1β release.
• NLRP3 activation contributes to tissue factor expression in sepsis-induced coagulation.
• Targeting the NLRP3 inflammasome presents a potential therapeutic strategy for preventing coagulation in sepsis.